Bigul

Q3FY24 &9MFY24 Quarterly Result Announced for Medi Assist Healthcare Services Ltd.

Healthcare services company Medi Assist Healthcare Services announced Q3FY24 & 9MFY24 results: Financial Highlights for Q3FY24: Total Income was Rs 169.8 crore, a growth of 29.2% with respect to Q3FY23. Revenue from contracts with customers (“Operating Revenue”) was Rs 165.9 crore, a growth of 32.3% with respect to Q3FY23. Adjusted Earnings Before Interest Taxes, Depreciation and Amortization excluding Other Income (“Operating EBITDA”) was Rs 33.9 crore, a growth of 10.4% with respect to Q3FY23. EBITDA margin calculated as Operating EBITDA divided by Operating Revenue was 20.4% for the quarter. Profit for the period was Rs 21.3 crore, flat over the corresponding period of the previous year Profit margin as a percentage of Total Income was 12.5%. Financial Highlights for 9MFY24: Total Income was Rs 481.9 crore, a growth of 26.9% over the corresponding period of the previous year. Revenue from contracts with customers (“Operating Revenue”) was Rs 467.9 crore, a growth of 26.8% over the corresponding period of the previous year. Earnings Before Interest Taxes Depreciation and Amortization excluding Other Income (“Operating EBITDA”) was Rs 96.3 crore, a growth of 8.6% over the corresponding period of the previous year. EBITDA margin calculated as Operating EBITDA divided by Operating Revenue was 20.6% for the period. Profit for the period excluding exceptional item was Rs 66.6 crore, a growth of 14.3% over the corresponding period of the previous year. Profit margin as a percentage of Total Income was 13.8%. The net cash balance in the books of the company was Rs 167.7 crore. Net worth was Rs 439.3 crore, return on net worth was 10.3%, and Return on Capital employed was 16.2% from continuing operations. Operational Highlights for 9MFY24: Total premiums under management for the company was Rs 14,163 crore, a growth of 35.7% over the corresponding period of the previous year. Premiums under management for the company with respect to the Group segment was Rs 12,352 crore, a growth of 34.5% over the corresponding period of the previous year. Premiums under management for the company with respect to the Retail segment was Rs 1,811 crore, a growth of 45% over the corresponding period of the previous year. Share of Total Industry health insurance premiums for the company with respect to the Group and Retail segment was 20.0%, a growth of 230bps over the corresponding period of the previous year. Share of industry health insurance premiums for the company with respect to the Group segment was 29.3%, a growth of 300bps over the corresponding period of the previous year. Share of industry health insurance premiums for the company with respect to the Retail segment was 6.3%, a reduction of 110bps over the corresponding period of the previous year. Commenting on the results, Satish Gidugu, CEO & whole-time Director, Medi Assist Healthcare Services said, “Our resilient performance in a growing health insurance market, demonstrates the strength of our business model. Our strategy as a company has been to focus on driving retention and growth, while successfully integrating the acquisitions. We see continued interest in our technology enabling ‘NHCX integration’ and ‘cashless anywhere’ towards driving innovation in the health insurance ecosystem.” Result PDF
13-02-2024
Bigul

Medi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Investor Presentation

Press Release titled Medi Assist Healthcare Services Q3 & 9M - FY 24
13-02-2024
Bigul

Medi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release titled Medi Assist Healthcare Services Q3 & 9M - FY 24
13-02-2024
Bigul

Medi Assist Healthcare Services Ltd - 544088 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For Quarter And Nine Months Ended December 31, 2023

Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for quarter and nine months ended December 31, 2023
13-02-2024
Bigul

Medi Assist Healthcare Services Ltd - 544088 - Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For Quarter And Nine Months Ended December 31, 2023

Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2023.
13-02-2024
Bigul

Medi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

This intimation is in furtherance to previous intimation dated February 06, 2024. Pursuant to Regulation 30 and Para A of Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company will hold the earnings conference call on Tuesday, February 13, 2024, at 06:00 P.M. (IST) to discuss the Company's financial results for the quarter and nine months ended December 31, 2023.
08-02-2024
Bigul

Medi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

The Company proposes to have a conference call to discuss the Company's financial and operational performance for the quarter and nine months ended December 31, 2023, scheduled to be held on Tuesday, 13th February 2024 at 06:00 pm. The details of the conference call will be intimated separately.
06-02-2024
Bigul

Medi Assist Healthcare Services Ltd - 544088 - Board Meeting Intimation for Board Meeting To Be Held On February 13, 2024:

Medi Assist Healthcare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 13, 2024, inter alia, to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended December 31, 2023.
06-02-2024
Next Page
Close

Let's Open Free Demat Account